Table 1.
Criterion | Detail |
---|---|
BCS classification | Outlining the documented class and any necessary background information on solubility or permeability, taking into consideration if a Biopharmaceutics Classification System (BCS) based biowaiver is possible. |
Bioequivalence study design | Design features generally include the study design and population, number of studies required, conditions of administration (fasting/fed or both) and strength(s) to be investigated. |
Analyte | Type of analyte to be measured and the medium to be investigated, also whether an enantioselective analytical method is required. |
Bioequivalence assessment | The main pharmacokinetic variables required to demonstrate bioequivalence and the related acceptance criteria. |